Literature DB >> 10434857

Treatment of dry eye by autologous serum application in Sjögren's syndrome.

K Tsubota1, E Goto, H Fujita, M Ono, H Inoue, I Saito, S Shimmura.   

Abstract

AIM: To evaluate the efficacy of autologous serum application for the treatment of dry eye in Sjögren's syndrome.
METHODS: The stability of essential components (EGF, vitamin A, and TGF-beta) in preserved serum were examined following preservation at 4 degrees C and -20 degrees C. In a primary clinical trial, 12 patients with Sjögren's syndrome were treated with autologous serum (diluted to 20% with sterile saline) for 4 weeks, and vital staining of the ocular surface was compared before and after treatment. The effects of serum on mucin (MUC-1) expression were observed in cultured conjunctival epithelial cells in vitro.
RESULTS: EGF, vitamin A, and TGF-beta were well preserved for up to 1 month in the refrigerator at 4 degrees C and up to 3 months in the freezer at -20 degrees C. Rose bengal and fluorescein scores improved significantly from the initial scores of 5.3 and 5.6 to 1.7 and 2.5 after 4 weeks, respectively. The additive effect of human serum for cultured conjunctival epithelial cells showed significant MUC-1 upregulation on the cell surface.
CONCLUSION: Autologous serum application is a safe and efficient way to provide essential components to the ocular surface in the treatment of dry eye associated with Sjögren's syndrome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10434857      PMCID: PMC1723012          DOI: 10.1136/bjo.83.4.390

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  35 in total

1.  Decreased reflex tearing is associated with lymphocytic infiltration in lacrimal glands.

Authors:  K Tsubota; K P Xu; T Fujihara; S Katagiri; T Takeuchi
Journal:  J Rheumatol       Date:  1996-02       Impact factor: 4.666

2.  Conjunctival transdifferentiation induced by systemic vitamin A deficiency in vascularized rabbit corneas.

Authors:  S C Tseng; M Farazdaghi; A A Rider
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-09       Impact factor: 4.799

3.  Epidermal growth factor (urogastrone) in human fluids: size heterogeneity.

Authors:  Y Hirata; D N Orth
Journal:  J Clin Endocrinol Metab       Date:  1979-04       Impact factor: 5.958

Review 4.  The dry eye: its mechanisms and therapy, with evidence that contact lens is a cause.

Authors:  R L Farris
Journal:  CLAO J       Date:  1986 Oct-Dec

5.  Staging of conjunctival squamous metaplasia by impression cytology.

Authors:  S C Tseng
Journal:  Ophthalmology       Date:  1985-06       Impact factor: 12.079

6.  Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca.

Authors:  R I Fox; R Chan; J B Michelson; J B Belmont; P E Michelson
Journal:  Arthritis Rheum       Date:  1984-04

7.  A new method for measuring tears.

Authors:  H Hamano; M Hori; T Hamano; S Mitsunaga; J Maeshima; S Kojima; H Kawabe; T Hamano
Journal:  CLAO J       Date:  1983 Jul-Sep

8.  Fluorometric determination of retinol in human tear fluid using high-performance liquid chromatography.

Authors:  A J Speek; E J van Agtmaal; S Saowakontha; W H Schreurs; N J van Haeringen
Journal:  Curr Eye Res       Date:  1986-11       Impact factor: 2.424

9.  Retinol secretion by the lacrimal gland.

Authors:  J L Ubels; K M Foley; V Rismondo
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-08       Impact factor: 4.799

10.  Basic fibroblast growth factor (FGFb) and epidermal growth factor (EGF) receptor messenger RNA production in human lacrimal gland.

Authors:  S E Wilson; S A Lloyd; R H Kennedy
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-09       Impact factor: 4.799

View more
  97 in total

1.  The ocular surface toxicity of paraquat.

Authors:  D McKeag; R Maini; H R Taylor
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

2.  [Epitheliotrophic capacity of serum and plasma eyedrops. Influence of centrifugation].

Authors:  P Herminghaus; G Geerling; D Hartwig; T Wedel; L Dibbelt
Journal:  Ophthalmologe       Date:  2004-10       Impact factor: 1.059

Review 3.  [Dry eye. An update on epidemiology, diagnosis, therapy and new concepts].

Authors:  F Schirra; K W Ruprecht
Journal:  Ophthalmologe       Date:  2004-01       Impact factor: 1.059

4.  An optimised protocol for the production of autologous serum eyedrops.

Authors:  L Liu; D Hartwig; S Harloff; P Herminghaus; T Wedel; G Geerling
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-09       Impact factor: 3.117

5.  Iodide iontophoresis as a treatment for dry eye syndrome.

Authors:  J Horwath-Winter; O Schmut; E-M Haller-Schober; A Gruber; G Rieger
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

6.  A novel use of amniotic membrane in the management of tube exposure following glaucoma tube shunt surgery.

Authors:  G Ainsworth; A Rotchford; H S Dua; A J King
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

7.  Combination of serum eye drops with hydrogel bandage contact lenses in the treatment of persistent epithelial defects.

Authors:  Stefan Schrader; Thilo Wedel; Ralf Moll; Gerd Geerling
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-17       Impact factor: 3.117

Review 8.  [Albumin eye drops for treatment of ocular surface diseases].

Authors:  J D Unterlauft; M Kohlhaas; I Hofbauer; K Kasper; G Geerling
Journal:  Ophthalmologe       Date:  2009-10       Impact factor: 1.059

Review 9.  Graft failure: II. Ocular surface complications.

Authors:  Samar A Al-Swailem
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

Review 10.  Autologous serum eye drops for ocular surface disorders.

Authors:  G Geerling; S Maclennan; D Hartwig
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.